#Risk Factors of Monkeypox

[apesoformythoughts]

"“Even if we found a silver bullet for AIDS tomorrow, something else would come along.” I wrote quickly to get distinguished psychiatrist Richard Pillard’s exact words down as he spoke at Columbia University’s HIV Center in the early 2000s. He ruefully admitted that the human immune system simply wasn’t designed to handle the frequent introduction of bodily fluids from multiple sexual partners. Our research, therefore, was the “hope for the future” that would free people to engage in the range of behaviors they desired without the consequences. The body may have limits, but sexual behaviors shouldn’t. Enter medical technology [...]

Our culture forgets that technology has provided a man-made shield against the natural consequences of unhealthy behaviors. Our collective vision is blurred, largely because there has been a purposeful decoupling of negative health outcomes from sexual behaviors in order to avoid stigmatizing the people engaging in them. Yet it can become a difficult dance when trying to state the facts while also trying to obscure them. HIV/AIDS has a vastly disproportionate impact on MSM/gay-identified men that has nothing to do with either innate susceptibility or unjust stigma; rather, it has everything to do with “two behavioral risk factors: receptive anal sex and promiscuity.”

However, from the number of partners to the type of sex, our cultural orthodoxy insists that the body and not the behavior is to blame. For instance, a 2019 article explained in detail that 80-90 percent of HIV infections would disappear in gay men if the transmission rate during anal intercourse were equal to that of vaginal intercourse. Because the risk in anal sex is eighteen times higher than vaginal, the author stated, “it’s not primarily behavior that puts gay men at such a high risk of HIV. It’s biology.” The fact is that the vagina, fit for sexual purpose, has rich protective layers of epithelial cells that “provide both structural and immunological defense mechanisms against STI pathogens.” Yet the HIV-risk article (since updated) reads as if such differences are mere happenstance. But such reasoning is to demand life in a world different from the one we inhabit—that male-to-male behavior be equally healthy and compatible with human biology as male-to-female."

— Jean C. Lloyd: "Monkeypox, Sexual Health, and the Limits of Medical Technology"

[sooptea]

Regular reminder to check your vaccinations -

> When was the last time you had a tetanus shot? If it's been more than 10 years you need a booster, and while you're at it get a Tdap instead of having just a Tetanus shot (three birds, one shot!)

> HPV vaccine? If you never got one I heavily recommend it

> If you're immunocompromised or over 50 you should see if you need a Pneumonia Vaccine. I got PCV20 back in 2022 and at this time I shouldn't need a booster for several decades (if ever)

> Do you need either a chickenpox or shingles shot? Fun fact did you know while Chickenpox is something you can only get once, shingles can happen multiple times!

> Are you at risk and need to get a monkeypox vaccine? Even if you are not a queer man there are other factors that can qualify you for this vaccine

> If your parents were anti-vax when you were a child, see if you need a MMR or Polio vaccine

> Check your hepatitis shots , did you finish getting all the ones you need?

Even if you've been healthy your whole life, these are still important to keep up on. If you have a weak immune system make sure you are working in your body's best interest

[nrkss]

A Comprehensive Guide to Prenatal Checkups

Prenatal care refers to the medical attention received during pregnancy. Your healthcare professional checks on you and your developing child at every appointment. These visits help medical professionals diagnose any issues early, administer required immunizations, and provide advice on lifestyle, diet, and general health. Meet the top obstetrician in Siliguri for prenatal checkups and expert advice.

Why Do Prenatal Exams Matter?

Track the mother's health and the growth of the fetus.

Determine and take care of any possible pregnancy issues.

Inform parents about postpartum care, labour, and delivery.

Give necessary immunizations and tests.

Provide psychological and emotional assistance.

The risk of pregnancy issues including gestational diabetes, hypertension, and birth abnormalities might rise if prenatal visits are skipped. A safe and secure pregnancy journey is ensured by routine appointments.

Prenatal Checkup Schedule

The stage of pregnancy determines how frequently prenatal appointments are scheduled:

Monthly visits during the first trimester (weeks 4–12).

Monthly visits during the second trimester (weeks 13–28).

Biweekly visits during the third trimester (weeks 29–36).

Weekly visits throughout the latter weeks (weeks 37–40).

More frequent visits may be necessary for women who have been diagnosed with high-risk pregnancies. Missing prenatal exams can raise the risk of issues including birth abnormalities, hypertension, and gestational diabetes.

Seeing an obstetrician-gynecologist (OBGYN) on a regular basis is crucial for all pregnancies. This helps make sure your pregnancy proceeds according to plan and that no unexpected issues come up. Here is a helpful guide to prenatal care to help you make the most of the experience and manage the demands of a pregnant visit schedule.

First Trimester Prenatal Appointment

A comprehensive record of your medical, psychiatric, gynecological, and obstetrical history will be compiled by your practitioner during your first trimester prenatal visit. It falls during the second month of pregnancy.

An OB-GYN will discuss your medical history and current health, including medication. The doctors may ask about your exposure to anything that could be toxic medications you take, including prescription and over-the-counter medications, vitamins, or supplements.

Your expert also talks about your lifestyle, including your use of tobacco, alcohol, caffeine, and recreational drugs, traveling to areas where malaria, tuberculosis, Zika virus, monkeypox, or other infectious diseases are common. Genetic testing, ultrasound, blood tests, and urine tests are mostly given.

Second Trimester Prenatal Appointment

During the second trimester of pregnancy, you may expect to see your OB-GYN less frequently. But they will also involve blood pressure, urine, and weight tests. To ensure your health and the health of the fetus, your pregnancy care provider will need to keep an eye on both of you during this phase.

Your doctor will measure the size of your abdomen, listen to your baby's heartbeat, check for fetal movements, including belly kicks or flutters, and evaluate your baby's growth during these visits.

At this point, you can be offered additional prenatal screenings or tests, such as an iron and blood count check, a gestational diabetes screening, Rh factor, and a genetic or chromosomal problem screening. Fetal ultrasounds are performed at this point to examine the anatomy of your body.

Third Trimester Prenatal Appointment

During the third trimester, your healthcare provider may enquire about any symptoms you may be experiencing. These include symptoms like bleeding, fluid leaks, or contractions. Doctors also measure your weight, blood pressure, and the heartbeat and movements of your infant.

Your OB-GYN will guide you to managing discomfort when to seek medical care, etc. At this phase, doctors also check the baby’s position, such as headfirst in the uterus, frank breech (bottom-first), complete breech (feet-first), and oblique (head is down but directed at one of your hips).

In weeks 35–37, doctors may order a test for group B strep test to look for germs that might harm the unborn child during birth. Week 36+ may be a cervical Exam: Determines whether labour is imminent.

Talk about the labour and delivery plan, including hospital protocols and preferences for giving birth. If necessary, the last ultrasound measures the baby's growth and the amount of amniotic fluid. Prenatal checkups are a fundamental part of a healthy pregnancy, ensuring both mother and baby receive the best possible care.

Attending regular visits, following medical advice, and staying informed about each stage of pregnancy can lead to a positive and smooth experience. Always consult your healthcare provider for any concerns and enjoy the journey to parenthood with confidence. Visit the best obstetrician in Siliguri City for thorough expert guidance and care.

Prenatal exams are essential for a successful pregnancy, looking after the health of both the mother and the unborn child. A good and easy experience might result from going to appointments regularly, listening to your doctor's recommendations, and keeping up with the latest developments about pregnancy. Consult your top obstetrician and gynaecologists in Siliguri for medical support.

[medicalbiochem]

Mpox: What You Need to Know About the Vaccine in 2024

What is Mpox?

Mpox (formerly known as monkeypox) is becoming a significant concern globally. You may be feeling uneasy about whether you need to protect yourself from the virus, especially with the rapid changes in vaccination guidelines. Are you unsure if the mpox vaccine is right for you in 2024? As vaccination efforts target various groups, it’s crucial to understand the facts. Should non-sexual individuals or healthcare professionals receive the vaccine? Let’s clarify the situation and examine the current recommendations, risk factors, and important details about the vaccine this year.

Why is the Mpox Vaccine Important?

The mpox vaccine plays a critical role in controlling outbreaks and preventing the further spread of the virus. The vaccine boosts your immune response to mpox. This makes it much less likely that you will experience severe symptoms if exposed to the virus. In 2024, health officials focused on high-risk groups and considered the changing dynamics of the virus.

Now that we understand what mpox is, let’s dive into who should consider getting the vaccine.

Who Should Get the Mpox Vaccine in 2024?

As of 2024, health authorities primarily recommended vaccinations against mpox for individuals in high-risk categories. While the virus can affect anyone, there are specific groups with a higher likelihood of exposure and serious infection. Understanding your risk level is key to deciding if you need the vaccine.

1. Doctors and Healthcare Workers

One of the most commonly asked questions is, “Do doctors get the mpox vaccine in 2024?” The answer depends largely on the nature of their work. Healthcare workers are at high risk of coming into contact with infectious diseases, especially those who work closely with skin or treat patients with viral infections.

Individuals handling mpox cases or those identified as high-risk should follow particular guidelines. Doctors are a priority group for vaccination because they are on the front lines, making them more susceptible to contracting and spreading the virus. The CDC and WHO have emphasized that even if healthcare workers are not in frequent contact with these patients, they should still evaluate their risk factors, particularly if their job involves exposure to bodily fluids.

2. Non-Sexual Individuals: Should You Get Vaccinated?

Another critical question is, “Should a non-sexual person receive the mpox vaccine in 2024?” While close contact transmission occurs, it is particularly prevalent within sexual networks and associated with the virus, but the virus does not only spread through sexual transmission. People can spread mpox by sharing personal items like towels, bedding, or clothing. They can also spread it through close physical contact, including respiratory droplets.

For non-sexual individuals, the risk may seem lower compared to those who are sexually active or frequently exposed to high-contact environments. For instance:

If you live with someone at high risk, such as a healthcare worker or an immunocompromised person, getting the vaccine adds a layer of protection.

If your job involves handling materials or working in environments of outbreak, consider getting vaccinated.

For frequent travelers, in areas with higher mumps infection rates. For individuals and in these regions, getting is necessary.

Vaccination decisions are complex for non-sexual individuals. Experts advise assessing personal risk and potential exposure to make an informed choice.

How Does the Mpox Vaccine Work?

The mpox vaccine uses a weakened virus to stimulate the body’s immune system, enabling it to recognize and fight off the mpox virus if exposed. The most common mpox vaccine used is the JYNNEOS vaccine, which also protects against smallpox, due to the similarities between the two viruses.

JYNNEOS is a two-dose vaccine administered four weeks apart, ensuring that recipients have robust immunity. Most people can tolerate the vaccine well. Mild side effects, such as soreness at the injection site or a low-grade fever, may occur.

Why is the Vaccine Especially Important in 2024?

The 2024 guidelines for the mpox vaccine reflect a growing understanding of how the virus spreads and who is most at risk. Now, public health experts recognize that broader vaccination efforts may be necessary. Experts also advise that immunity from the vaccine may wane over time, leading to the possibility of booster shots in the coming years.

Addressing Common Concerns

1. Is the Vaccine Safe for Everyone?

The mpox vaccine is considered safe for most people, including individuals with weakened immune systems. However, it’s important to consult your healthcare provider if you have a history of severe allergies or adverse reactions to vaccines.

2. Does Vaccine Prevent All Mpox Cases?

No vaccine provides 100% protections, but the vaccine significantly reduces the risk of severe illness and hospitalization. Vaccinated people can still contact mpox. However, their symptoms are likely to be milder and less prolonged compared to those who are not vaccinated.

3. How Long Does the Vaccine Provide Protection?

Current data suggests that the vaccine provides protection for several years. However, as research continues, recommendations may shift towards booster doses, especially for those in high-risk categories.

Mpox and Public Perception

Since the mpox outbreak, concerns have arisen about who is eligible for the vaccine. Many people have expressed their concerns about the mpox vaccine recipients. They fear they may not fit the typical “at-risk” profile. It’s crucial to dispel myths around mpox. The virus is not exclusive to any one group, and anyone in close contact with an infected individual can catch it. Vaccination is not limited to sexually active individuals or healthcare workers. Everyone should assess their own exposure risks.

The 2024 vaccination strategy takes into account the shifting dynamics of the virus, and public health bodies are working hard to ensure that those who need it most can access the vaccine. Non-sexual individuals may not seem like an immediate priority for vaccination. However, they can still find value in getting vaccinated if certain circumstances warrant it.

Conclusion:

In 2024, the mpox vaccine continues to be a vital tool in curbing the spread of this virus. Whether you’re a doctor, healthcare worker, or simply trying to navigate your risk as a non-sexual person, it’s essential to stay informed. Doctors and healthcare workers are urged to get vaccinated, given their high exposure to potential infections. Non-sexual individuals should weigh their personal exposure risk, living situation, and professional environment to determine if vaccination is necessary.

The mpox vaccine is a critical measure to prevent outbreaks and protect the most vulnerable. As we move further into 2024, stay updated on the latest guidelines and make sure to consult your healthcare provider to make the best decision for your health.

[unvindiaannouncements]

MPox

On August 14, 2024, the World Health Organization (WHO) declared monkeypox, now referred to as Mpox, a global public health emergency. This declaration follows the rapid spread of the disease across 13 African countries, notably including Congo, where 14,000 cases and 524 deaths have been reported. This is the second time in three years that Mpox has reached such an emergency status.

Current Status and Spread

Mpox has been identified in at least 13 African countries, with over 96% of cases and deaths concentrated in Congo. New outbreaks have also been detected in Burundi, Kenya, Rwanda, and Uganda, linked to the epidemic in Congo. The number of cases has surged by 160% this year, with deaths increasing by 19%. A concerning factor in the current outbreak is the emergence of a new clade of the virus, which manifests with lesions on the genitals, complicating detection and facilitating unnoticed transmission.

Transmission and Symptoms

Monkeypox spreads through direct contact with infected individuals or contaminated objects, and can also be transmitted from animals to humans. Common symptoms include rash, fever, sore throat, headache, muscle aches, back pain, low energy, and swollen lymph nodes. Severe cases can lead to complications such as pneumonia, vision loss, sepsis, and, in extreme cases, death.

Global Response and WHO Actions

The WHO is actively working to contain the spread by supporting affected countries, providing resources for testing and treatment, and coordinating with partners such as the Africa CDC and NGOs. A regional response plan has been developed, requiring an initial $15 million, with $1.5 million already released from the WHO Contingency Fund for Emergencies.

Situation in India

India reported its first case of monkeypox in 2022, and as of July 24, 2023, there have been 27 confirmed cases in the country, with cases reported in Kerala and Delhi.

Preventive Measures

To mitigate the risk of monkeypox, individuals should practice good hygiene, avoid close contact with symptomatic individuals, use personal protective equipment when caring for infected individuals, and avoid handling or consuming wild animals showing signs of illness.

About the writer:

Javad Ahmad Hura, Teacher,

G D Goenka Public school,

Srinagar

[blogdukosova]

Health Trends: Identifying Common Sicknesses in the USA Today

Identifying Common Sicknesses in the USA Today: Top Trends and Insights

Here's a glimpse into some of the most common illnesses currently affecting the USA, along with insights into their prevalence and recent trends:Respiratory Illnesses:COVID-19: While cases have declined from the peak, COVID-19 remains a prevalent concern, with new variants and subvariants emerging. Vaccination and preventive measures like mask-wearing are crucial. Influenza: The 2023-2024 flu season is predicted to be moderately severe, with influenza A viruses dominating. Early vaccination is highly encouraged. RSV (Respiratory Syncytial Virus): An upsurge in RSV cases, particularly among infants and young children, has been observed in recent months. Anxiety and Depression: The prevalence of these conditions has significantly increased, particularly among youth and young adults. Access to mental health resources remains a challenge. Substance Abuse: Opioid overdoses continue to be a major public health crisis, with synthetic opioids like fentanyl driving fatalities. Heart Disease: Leading cause of death in the USA, with risk factors like obesity, high blood pressure, and lack of physical activity contributing significantly. Cancer: A major public health threat, with various types showing concerning trends like rising colorectal cancer incidence among young adults. Monkeypox: Although cases have declined, continued vigilance and vaccination efforts are necessary to prevent further spread. Antibiotic Resistance: The growing threat of antibiotic-resistant bacteria poses a significant challenge to treating common infections. Climate Change: Increasing temperatures and extreme weather events can exacerbate existing health problems and contribute to the emergence of new ones. Health Disparities: Racial and socioeconomic disparities in healthcare access and outcomes persist, requiring policy and systemic changes. Read the full article

[broadlyepi]

MMWR Booster #36:  Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022

Top 5 Takeaways

Among 57 patients hospitalized for severe monkeypox during the study period, most were Black men with AIDS, highlighting the severe impact of monkeypox in immunocompromised individuals.

Twelve patients died, with monkeypox being a cause or contributing factor in five cases. Delays in initiating monkeypox-directed therapies were noted.

A high percentage of the patients (82%) had HIV infection, and most received intensive care; early treatment with available therapeutics is advised for those at risk.

The study reveals inequities in healthcare access and emphasizes the need for public health outreach, especially in marginalized communities.

The report urges clinicians to start early treatment for suspected or confirmed monkeypox, particularly in patients with severe immunocompromise, and to test all sexually active patients with suspected monkeypox for HIV.

Note:

This MMWR Article was created prior to the conventional renaming of Monkeypox to its more standard and appropriate name, Mpox. To avoid confusion, Monkeypox is retained when writing this article, but all future works should use Mpox.

Full summary link: BroadlyEpi.com

Enjoying these summaries? Check back every day at 8am and 4pm Pacific Time (UTC - 8) for a new MMWR Booster. A reblog would also be greatly appreciated, and thanks to everyone who already has! BroadlyEpi hopes to make Epidemiology and Public Health more approachable to anyone who's interested.

[pathogenprobinghub]

Monkeypox and Climate Change: Exploring Possible Connections

Monkeypox, a rare viral disease that primarily affects humans and other primates, has been a topic of concern in recent years. The emergence and spread of infectious diseases are often influenced by various factors, and one such factor that has gained attention is climate change. This article delves into the potential connections between monkeypox and climate change, exploring how shifts in climate patterns may impact the prevalence and distribution of this disease.

Understanding Monkeypox

Monkeypox is a zoonotic disease, meaning it can be transmitted from animals to humans. The virus is primarily found in animals such as rodents and monkeys, with humans getting infected through direct contact with the animals or their bodily fluids. While monkeypox is mostly endemic to Central and West African countries, sporadic cases have been reported outside this region.

Climate Change and its Impact on Disease Dynamics

Climate change, driven by factors such as rising temperatures, altered precipitation patterns, and changes in ecosystems, can have profound effects on the distribution and transmission of infectious diseases. One of the key ways climate change influences disease dynamics is by affecting the habitat and behavior of vectors, which are organisms that transmit pathogens.

In the case of monkeypox, the potential link to climate change becomes evident when considering the habitats of its natural hosts, such as rodents. Changes in temperature and precipitation patterns can impact the distribution of these animals, altering their habitats and potentially bringing them into closer contact with human populations. This increased interaction raises the risk of zoonotic transmission, leading to a higher incidence of monkeypox in areas where the virus was previously less prevalent.

Vector Dynamics and Monkeypox Transmission

Rodents, particularly certain species of African rodents, are known to harbor the monkeypox virus. As climate change alters the distribution of these rodent species, it can impact the prevalence of the virus in their populations. Warmer temperatures and changes in precipitation may create conditions favorable for the proliferation of specific rodent species, increasing the likelihood of monkeypox transmission.

Furthermore, alterations in climate patterns can affect the behavior of vectors like mosquitoes and ticks, which may play a role in the transmission of monkeypox. These vectors are sensitive to changes in temperature and humidity, and climate change can create more suitable environments for them to thrive. If these vectors become more abundant in areas where monkeypox is present, it could contribute to the spread of the disease to new regions.

Human Behavior and Climate Change

Apart from the impact on animal hosts and vectors, climate change can also influence human behavior in ways that contribute to the spread of infectious diseases. Changes in temperature and weather patterns can affect agricultural practices, water availability, and human migration patterns. Disruptions to these systems can lead to increased human-animal contact, facilitating the transmission of diseases like monkeypox.

For example, if changing climate conditions affect the availability of certain food sources, communities may be compelled to hunt or gather resources in new areas, potentially bringing them into contact with wildlife and increasing the risk of zoonotic transmission. Additionally, altered precipitation patterns can influence water scarcity, prompting people to rely on alternative water sources that may be contaminated, further contributing to the spread of infectious diseases.

Adaptation and Mitigation Strategies

Recognizing the potential links between monkeypox and climate change highlights the importance of implementing effective adaptation and mitigation strategies. Enhancing surveillance systems to monitor changes in the prevalence of the disease, promoting public awareness about the risks associated with specific behaviors, and developing strategies to manage vector populations are crucial steps in addressing the intersection of monkeypox and climate change.

Furthermore, global efforts to mitigate climate change itself can indirectly contribute to preventing the spread of infectious diseases. Reducing greenhouse gas emissions, conserving biodiversity, and promoting sustainable land-use practices are essential components of a comprehensive approach to addressing both climate change and emerging infectious diseases.

Conclusion

The complex relationship between monkeypox and climate change underscores the interconnectedness of environmental, animal, and human health. As climate change continues to shape our planet, understanding and addressing the potential impacts on infectious diseases become imperative. By adopting a holistic and collaborative approach that considers ecological, social, and economic factors, we can work towards mitigating the risks posed by diseases like monkeypox and building a more resilient and sustainable future.

0 notes

[zoneofblog]

The disease was first reported in 1958 in the Democratic Republic of Congo and has been found in other African countries, including Nigeria and Uganda. The virus can be transmitted to humans from contact with infected animals or through droplets from coughing or sneezing.

[wumblr]

since everyone in public health is dead at the wheel, you should know: monkeypox has a r0 value of about 2 (omicron BA2 and measles are both near 12, which is about the maximum we know of, until we get clearer data on BA4/5 next month).

r0 value is number of likely infections per patient, so that also means monkeypox infections will likely double until it reaches peak infection. this could be a million people by the end of the year because it is 400 now (in the US).

it is aerosol and fomite transmissible. fomite viral particles survive in the environment for two months.

vaccination is currently available only for confirmed cases, and we will likely only be able to produce a million doses by end of year. they will likely not be distributed to the most at-risk people. this will likely not be enough to prevent widespread infection. i might recommend seeking testing in absence of symptoms, to catch any asymptomatic infections.

anyone born before 1980 is likely to already be vaccinated for it (smallpox vaccination seems to remain 85% effective with no waning, although the new vaccine recommended is jynneos and healthcare providers are hesistant to offer the older vaccine because it scars the injection site). if you're 40+ it might be a good time to get into volunteer outreach or hospice care.

it may have a fatality rate between 1-10%, more likely 1-3%, this is affected by factors like overall immune vulnerability, nutrition, and heatlh. severe progression is characterized by nausea, dizziness, shortness of breath, and other systematic-failure indicators. the virus had already mutated substantially by the time it was detected, so this may be an indicator that there are far more unknown, mild cases (i.e. bringing the fatality rate down substatially, one would hope.)

it is distinguishable from chickenpox because the sores progress at the same rate, while in chickenpox each sore may be at different stages. any healthcare provider or sexual health clinic will likely be able to test for both. now is not the time to ignore symptoms. petechiae are also a post-covid associated sequala, i believe they also progress at different rates like chickenpox but i'm not sure if there's a clear clinical definition of covid sores yet. it's also possible these represent undetected pox cases. it was likely circulating as early as april.

monkeypox infection may cause as a few as one sore, which scabs and then peels. debridement or exfoliation is not recommended, precisely because viral particles can survive for two months, although it's believed to stop being transmissible after the first layer of skin heals. vitamin A is recommended during recovery, ideally from nutritionally dense foods.

chickenpox can also cause facial paralysis. hepatitis-associated liver failure in children has been essentially confirmed as a post-covid sequela (adenovirus was ruled out as a cause of hepatitis, if you heard about that, although it is also still endemic). dysentery, cholera, and polio are back. between 10-30% of covid patients are now likely immunocompromised from long covid, although severe cases are less than 10%.

our failure to manage this has damaged the collective immune imprint, things that used to be rare or eradicated can now gain a foothold much more easily. this will keep happening until we end capitalism, we didn't have to live with influenza or salmonella either, and they make bank off the 1.3m deaths of heart disease and cancer every year too.

correct me if i'm wrong but i'm pretty sure everything except that last part is stated in this PDF. also had to look up the r0 value separately, i don't think that's in there

[mybeautifulchristianjourney]

The Truth about Monkeypox

According to an NBC News report:

* Research strongly suggests that GAY sex between men is fueling the global monkeypox outbreak. NOT skin contact.

* Since the global monkeypox outbreak the media and government health agencies around the world have advanced the false claim that transmission is through physical (skin) contact as opposed to transmission being through oral and anal gay sex.  (They made a conscious decision to knowingly suppress research data in order to protect the LGBT community from public stigma)

* An expanding number of infectuous disease experts have informed the W.H.O. that sexual transmission of monkeypox through oral and anal intercourse between gay men is the primary driver of the global monkeypox outbreak. These same experts say skin to skin contact that comes with sex is much less a risk factor.

* It is impossible for children to get monkeypox UNLESS they have been subject to sexual abuse. (I.E. if a child gets monkeypox, someone should be going to JAIL).

On a personal note this shows how powerful the Gay Community truly is. They can have the news media of the ENTIRE world deliberately mislead everyone else just to keep them from being blamed for a global health threat their promiscuous lifestyle fueled. LGBTQ’s are NOT victims. WE are. Victims of their lies. Victims of their manipulation of scientific research. Victims of their unhealthy lifestyle. They control the media. They control entertainment. They control Big Tech. They control public education. They control the fortune 500 Corporations. They control professional athletics. Yet they’ll play that victim card as long as they can. The only reason we’re even getting the truth now is because even the media couldn’t keep it from getting out this time. I already know their excuse “We didn’t know... we were told... blah blah blah.”

* highlighted italicized text is my personal opinion

[atlanticcanada]

Appointments for second dose of monkeypox vaccine now available in N.S.

As Nova Scotia continues to avoid outbreaks of monkeypox, health officials are taking the next step to help prevent the most vulnerable from being exposed to the virus.

Appointments opened up Friday for those who are at the highest risk of monkeypox exposure to receive their second dose of Imvamune vaccine, which helps protect against infection prior to exposure.

According to the National Advisory Committee on Immunization (NACI), Imvamune is recommended as a preventative two-dose vaccine, with an interval between doses of at least 28 days.

"We are following NACI's recommendations by expanding the eligibility of the vaccine and offering second doses to those at highest risk," said Dr. Jesse Kancir, medical officer of health responsible for monkeypox, in a Friday news release. "While second dose appointments are now available, I want to remind people who are eligible that it is not too late to get your first dose. Getting vaccinated can help protect against a potential monkeypox infection."

Those who are eligible for an Imvamune vaccine can be immunized, for free, at the Halifax Sexual Health Centre until at least Nov. 10.

A second clinic is set to open in Sydney, N.S., during the week of Nov. 7. More information about the Cape Breton clinic is expected to be released next week.

The provincial government says more monkeypox clinics are in the works in other parts of Nova Scotia.

The pre-exposure vaccination program follows strict guidelines, as Imvamune doses are in short supply.

Recipients must identify as a cisgender or trans queer man, a two-spirit person or a non-binary person, or as someone who has sexual contact with individuals in these communities. Additional eligibility factors include having two or more sexual partners since May, a diagnosis of a bacterial sexually transmitted infection since May, or having been present at a bath house or sex club. Individuals who have had anonymous sex in the past five months, or who have engaged in sex work are also encouraged to get the monkeypox vaccine.

Imvamune vaccines are only available to residents of Nova Scotia, as well as those living in the province for post-secondary education or for work. Appointments for monkeypox vaccines are available online or by calling the Halifax Sexual Health Centre at 902-455-9656.

Nova Scotia Health warns that monkeypox spreads through close contact with an infected person, including during sexual activity, direct contact with monkeypox spores, inhaling respiratory droplets from coughs or sneezes from an infected person, and contact with contaminated items like bedding or clothing.

Symptoms of monkeypox are known to develop five to 21 days after being exposed to the virus. Early onset symptoms include fever, chills, swollen lymph nodes, headache, muscle pain, joint pain, back pain, and exhaustion. As symptoms progress, a rash or sore usually starts on the face, legs, or arms and can affect other parts of the body including hands, feet, mouth and genitals.

Nova Scotia confirmed its first case of monkeypox on Aug. 23.

The World Health Organization first declared the monkeypox outbreak a global health emergency on July 23.

from CTV News - Atlantic https://ift.tt/4QFEyKS

[sexualnews12]

National campaign to raise awareness of monkeypox

By Emen8, updated 6 months ago in Health / Sexual health Emen8’s latest national campaign raises awareness of monkeypox in Australia to help prevent outbreak. Our campaign, Prick – Pause – Play, features messages around knowing the symptoms, risk factors, prevention strategies and the importance of getting the vaccine. Emen8 is a national online sexual health and wellbeing resource for gay,…

[sciencespies]

New approach predicts disease transmission among wildlife and humans

https://sciencespies.com/nature/new-approach-predicts-disease-transmission-among-wildlife-and-humans/

New approach predicts disease transmission among wildlife and humans

The rate that emerging wildlife diseases infect humans has steadily increased over the last three decades. Viruses, such as the global coronavirus pandemic and recent monkeypox outbreak, have heightened the urgent need for disease ecology tools to forecast when and where disease outbreaks are likely.

A University of South Florida assistant professor helped develop a methodology that will do just that — predict disease transmission from wildlife to humans, from one wildlife species to another and determine who is at risk of infection.

The methodology is a machine-learning approach that identifies the influence of variables, such as location and climate, on known pathogens. Using only small amounts of information, the system is able to identify community hot spots at risk of infection on both global and local scales.

“Our main goal is to develop this tool for preventive measures,” said co-principal investigator Diego Santiago-Alarcon, a USF assistant professor of integrative biology. “It’s difficult to have an all-purpose methodology that can be used to predict infections across all the diverse parasite systems, but with this research, we contribute to achieving that goal.”

With help from researchers at the Universiad Veracruzana and Instituto de Ecologia, located in Mexico, Santiago-Alarcon examined three host-pathogen systems — avian malaria, birds with West Nile virus and bats with coronavirus — to test the reliability and accuracy of the models generated by the methodology.

The team found that for the three systems, the species most frequently infected was not necessarily the most susceptible to the disease. To better pinpoint hosts with higher risk of infection, it was important to identify relevant factors, such as climate and evolutionary relationships.

By integrating geographic, environmental and evolutionary development variables, the researchers identified host species that have previously not been recorded as infected by the parasite under study, providing a way to identify susceptible species and eventually mitigate pathogen risk.

“We feel confident that the methodology is successful, and it can be applied widely to many host-pathogen systems,” Santiago-Alarcon said. “We now enter into a phase of improvement and refinement.”

The results, published in the Proceedings of the National Academy of Sciences, prove the methodology is able to provide reliable global predictions for the studied host-pathogen systems, even when using a small amount of information. This new approach will help direct infectious disease surveillance and field efforts, providing a cost-effective strategy to better determine where to invest limited disease resources.

Predicting what kind of pathogen will produce the next medical or veterinary infection is challenging, but necessary. As the rate of human impact on natural environments increases, opportunity for novel diseases will continue to rise.

“Humanity, and indeed biodiversity in general, are experiencing more and more infectious disease challenges as a result of our incursion and destruction of the natural order worldwide through things like deforestation, global trade and climate change,” said Andrés Lira-Noriega, research fellow at the Instituto de Ecologia. “This imposes the need of having tools like the one we are publishing to help us predict where new threats in terms of new pathogens and their reservoirs may occur or arise.”

The team plans to continue their research to further test the methodology on additional host-pathogen systems and extend the study of disease transmission to predict future outbreaks. The goal is to make the tool easily accessible through an app for the scientific community by the end of 2022.

Story Source:

Materials provided by University of South Florida. Note: Content may be edited for style and length.

#Nature

[mbdailynews]

Monkeypox Outbreak Shows Signs of Cooling in U.S. and Globally

The pace of new monkeypox cases may be slowing in hot spots including New York City, health officials said, offering hope that an outbreak that has sickened more than 46,000 people globally is cooling. In the U.S., which has the most known cases globally, factors including outreach and vaccines are helping to curb the spread in New York City, the health department there said. There are also some early signs that the rate of new case growth may be waning in Europe, where monkeypox cases started piling up in May, according to the World Health Organization. Public-health experts said at the wall street journal digital subscription they remain cautious about whether the outbreak has peaked, as efforts continue to stretch limited vaccine supplies and protect people vulnerable to catching the viral disease, which has overwhelmingly affected men who have sex with men. Get 3 Years Digital Subscription of The Wall Street Journal for $69 “If anything, we need to continue to strongly communicate and educate the public about this pathogen,” said Rodney Rohde, a public-health expert at Texas State University. Officials remain cautious about declaring the outbreak has peaked, however, and continue the vaccination push in hot spots such as Florida’s Miami-Dade County.   Ashwin Vasan, commissioner of New York City’s Department of Health and Mental Hygiene, credited vaccination efforts, outreach from community leaders and the public’s response for contributing to a slowing in cases and transmission. “All of this is clearly taking hold and having a positive effect in slowing this outbreak,” Dr. Vasan said at wall street journal print edition online Since May, at least 46,337 monkeypox cases have been reported in about 90 countries where the disease is uncommon, according to Centers for Disease Control and Prevention data. While Europe was hit hard early on, the U.S. now has roughly one-third of known cases. About 17,000 cases have been reported in all 50 U.S. states, Washington, D.C., and Puerto Rico, the CDC said at wall st journal print edition The Biden administration declared monkeypox a public-health emergency in early August, following a WHO declaration of a global-health emergency in July. The WHO said the number of new reported cases globally declined by 21% in the week that ended Aug. 21, following four consecutive weeks of increases. The drop may reflect early signs of a declining case count in Europe, though that needs to be confirmed, the WHO said. Subscribe to The New York Times 3 Years for $69 Federal health authorities have faced challenges as they have attempted to contain the outbreak, even though monkeypox was a known disease that could have been guarded against. Testing, necessary to identify cases and track the outbreak’s trajectory, was limited early on. The U.S. has also faced criticism for not moving more quickly to secure adequate vaccine doses. A proactive response in at-risk communities has helped to slow the spread of the virus, epidemiologists said. Monkeypox can spread through close skin-to-skin contact and contact with contaminated objects like clothing and bedding. Cases can be extremely painful for some people. According to an online survey earlier this month by Emory University, a significant number of men who have sex with men have changed their behavior because of the outbreak. About 50% of the men surveyed said they had reduced their number of sex partners. Buy The Economist and The New York News Times 3 Years for $89 “I’m cautiously optimistic,” said Peter Chin-Hong, a professor of medicine at the University of California, San Francisco. He said he remained concerned about college students as the fall semester begins, and about at-risk people who haven’t been vaccinated or have received one dose. Protection is highest two weeks after receiving a second shot of the vaccine, the CDC has said. The concentration of monkeypox DNA detected in San Francisco-area wastewater has stabilized in recent weeks, suggesting a leveling-off of the virus. Monkeypox, a virus related to smallpox, was rarely detected outside Africa before this outbreak. The type of monkeypox spreading globally is considered a less-severe variety. Deaths have been rare, though a handful of people have died in countries where the virus isn’t endemic. Read the full article

[latestnewsfeedsposts]

U.S. Offers Extra Monkeypox Vaccine Doses for Pride Events

U.S. Offers Extra Monkeypox Vaccine Doses for Pride Events

NEW YORK — The U.S. is setting aside an extra 50,000 doses of monkeypox vaccine for places with upcoming gay pride events, health officials said Thursday. The number of doses sent to each will be based on factors like the size of the event, how many health workers will be available to give shots, and how many of the attendees are considered at highest risk for catching the virus. “More shots in…